WASHINGTON (AP) - Federal health officials say patients taking a Bristol-Myers Squibb drug for HIV have reported a rare, but potentially fatal liver disorder.
The Food and Drug Administration says it received 42 reports of the disorder since Videx was approved in 1991. Four patients died from bleeding or liver failure after developing the problem, known as non-cirrhotic portal hypertension.
The problem involves dangerously slow blood flow though the liver, which can cause veins in the esophagus to swell. These veins are thin and can cause burst, causing potentially deadly bleeding.
FDA says it is keeping the drug on the market because its benefits outweigh its risks. The agency added warnings to the drug's label about the signs of the liver disorder.
(Copyright 2010 by The Associated Press. All Rights Reserved.)
Web Search powered by YAHOO!
|
LifestylesLifestyles
FDA liver risk warning for Bristol-Myers HIV drug
WASHINGTON (AP) - Federal health officials say patients taking a Bristol-Myers Squibb drug for HIV have reported a rare, but potentially fatal liver disorder.
By:
|
WNCT
Published: February 01, 2010
Published: February 01, 2010
Email
Facebook
Google
Twitter
Favorites
MoreAdvertisement
View More:
Associated Press,
Bristol-Myers Squibb,
Disorder,
Fatal Liver Disorder,
Food And Drug Administration,
Health_Medical_Pharma,
Hiv,
Liver Disorder,
Liver Failure,
Non-Cirrhotic Portal Hypertension,
Social Issues,
Videx,
Washington
Not what you're looking for? Try our quick search:
Reader Comments
*Facebook Account Required to Comment. If you are not already logged into Facebook, please click the comment button to do so.Deal of the Day
Advertisement
Interactive Radar
Advertisement
Featured Blogger
Reel Reviews
Updated: 02/10/2012
Nine On Your Side's Phillip Sayblack shares his take on the latest movie and dvd releases.
More Posts by Reel Reviews
Hot Topics on WNCT.com
Advertisement
Advertisement